» Authors » Isabelle Vinatier

Isabelle Vinatier

Explore the profile of Isabelle Vinatier including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 33
Citations 513
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mathieu A, Reignier J, Le Gouge A, Plantefeve G, Mira J, Argaud L, et al.
Crit Care . 2024 Jul; 28(1):237. PMID: 38997759
Background: Critical-illness survivors may experience post-traumatic stress disorder (PTSD) and quality-of-life impairments. Resilience may protect against psychological trauma but has not been adequately studied after critical illness. We assessed resilience...
2.
Paccoud O, Chamillard X, Kendjo E, Vinatier I, Surgers L, Magne D, et al.
Int J Infect Dis . 2023 Nov; 137:144-148. PMID: 37926196
Objectives: Positive direct antiglobulin tests (DATs) have been reported in cases of post-artesunate delayed hemolysis (PADH), but the causal role of auto-immune hemolysis remains unclear. We aimed to analyze a...
3.
Francois B, Lambden S, Fivez T, Gibot S, Derive M, Grouin J, et al.
Lancet Respir Med . 2023 Jun; 11(10):894-904. PMID: 37269870
Background: Activation of the triggering receptor expressed on myeloid cells-1 (TREM-1) pathway is associated with septic shock outcomes. Data suggest that modulation of this pathway in patients with activated TREM-1...
4.
Reignier J, Plantefeve G, Mira J, Argaud L, Asfar P, Aissaoui N, et al.
Lancet Respir Med . 2023 Mar; 11(7):602-612. PMID: 36958363
Background: The optimal calorie and protein intakes at the acute phase of severe critical illness remain unknown. We hypothesised that early calorie and protein restriction improved outcomes in these patients,...
5.
Reignier J, Le Gouge A, Lascarrou J, Annane D, Argaud L, Hourmant Y, et al.
BMJ Open . 2021 May; 11(5):e045041. PMID: 33980526
Introduction: International guidelines include early nutritional support (≤48 hour after admission), 20-25 kcal/kg/day, and 1.2-2 g/kg/day protein at the acute phase of critical illness. Recent data challenge the appropriateness of...
6.
Nguyen T, Maenulein E, Fihman V, Vinatier I, Moh Klaren J
Transfusion . 2021 Mar; 61(5):1609-1616. PMID: 33686704
Background: Oxaliplatin, a third-generation platinum derivative is commonly used in combination treatment of metastatic colorectal cancer. Since 2008, it is the second most common cause of drug-induced immune hemolytic anemia...
7.
Boissier F, Seegers V, Seguin A, Legriel S, Cariou A, Jaber S, et al.
Crit Care . 2020 Aug; 24(1):521. PMID: 32843097
Background: As an increasing number of deaths occur in the intensive care unit (ICU), studies have sought to describe, understand, and improve end-of-life care in this setting. Most of these...
8.
Lemiale V, De Jong A, Dumas G, Demoule A, Mokart D, Pene F, et al.
Crit Care Med . 2020 Jul; 48(9):e768-e775. PMID: 32706556
Objectives: To assess the response to initial oxygenation strategy according to clinical variables available at admission. Design: Multicenter cohort study. Setting: Thirty French and Belgium medical ICU. Subjects: Immunocompromised patients...
9.
Nguyen T, Fihman V, Maenulein E, Vinatier I, Moh Klaren J
Transfus Clin Biol . 2020 Jun; 27(3):133-138. PMID: 32561329
Objectives: Testing for drug-dependent antibodies is traditionally performed with the tube method either with drug-treated red blood cells or with untreated red blood cells in the presence of soluble drug....
10.
Robert R, Le Gouge A, Kentish-Barnes N, Adda M, Audibert J, Barbier F, et al.
Intensive Care Med . 2020 Jan; 46(6):1194-1203. PMID: 31996960
Purpose: Little is known on the incidence of discomfort during the end-of-life of intensive care unit (ICU) patients and the impact of sedation on such discomfort. The aim of this...